Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

29
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
29
Obesity01:24

Obesity

1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
The Oral Microbiota01:27

The Oral Microbiota

87
The oral microbiome includes a complex ecosystem comprising over 700 microbial species, identified through genomic sequencing and culture-based analyses to date. This community includes a core microbiome, found universally among individuals, and a variable component influenced by environmental factors such as diet, lifestyle, and host genetics. Site-specific conditions, including oxygen gradients, pH levels, and nutrient availability, determine the spatial distribution of these microorganisms...
87
Gut-Brain Axis01:22

Gut-Brain Axis

207
The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...
207
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

162
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
162
Functions of the Gut Microbiota01:18

Functions of the Gut Microbiota

145
The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
145

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of the feed additive consisting of <i>Lactiplantibacillus plantarum</i> (formerly <i>Lactobacillus plantarum</i>) DSM 21762 for all animal species for the renewal of its authorisation (Lactosan GmbH & Co KG).

EFSA journal. European Food Safety Authority·2021
Same author

Assessment of the feed additive consisting of copper chelate of hydroxy analogue of methionine for all animal species for the renewal of its authorisation (Novus Europe S.A./N.V.).

EFSA journal. European Food Safety Authority·2021
Same author

Bacteroides uniformis CECT 7771 alleviates inflammation within the gut-adipose tissue axis involving TLR5 signaling in obese mice.

Scientific reports·2021
Same author

The Microbiota and the Gut-Brain Axis in Controlling Food Intake and Energy Homeostasis.

International journal of molecular sciences·2021
Same author

Safety and efficacy of a feed additive consisting on the bacteriophages PCM F/00069, PCM F/00070, PCM F/00071 and PCM F/00097 infecting <i>Salmonella</i> Gallinarum B/00111 (Bafasal<sup>®</sup>) for all avian species (Proteon Pharmaceuticals S.A.).

EFSA journal. European Food Safety Authority·2021
Same author

The gut microbiota as a versatile immunomodulator in obesity and associated metabolic disorders.

Best practice & research. Clinical endocrinology & metabolism·2021

Related Experiment Video

Updated: Apr 27, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

29.3K

Microbiota, inflammation and obesity.

Yolanda Sanz1, Angela Moya-Pérez

  • 1Microbial Ecology, Nutrition & Health, National Research Council (IATA-CSIC), Av. Agustín Escardino 7, 46980, Paterna, Valencia, Spain, yolsanz@iata.csic.es.

Advances in Experimental Medicine and Biology
|July 6, 2014
PubMed
Summary

Obesity impairs immune function, increasing infection risk and chronic inflammation. Gut microbiota changes drive this inflammation, impacting metabolism and leading to diseases like insulin resistance and type-2 diabetes.

More Related Videos

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
07:46

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

24.6K
An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

6.4K

Related Experiment Videos

Last Updated: Apr 27, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

29.3K
Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
07:46

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

24.6K
An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

6.4K

Area of Science:

  • Immunology
  • Metabolic disease
  • Microbiome research

Background:

  • Obesity is linked to immune dysfunction, increasing susceptibility to infections and chronic inflammation.
  • This chronic inflammation contributes to metabolic disorders such as insulin resistance and type-2 diabetes.
  • Gut microbiota plays a crucial role in initiating inflammation associated with obesity and metabolic dysfunction.

Purpose of the Study:

  • To review the intricate relationship between gut microbiota, metabolism, and immunity.
  • To elucidate how diet and obesity alter gut microbiota composition and immune activation.
  • To discuss the impact of gut microbiota on innate and adaptive immunity in obesity-related diseases.

Main Methods:

  • Review of current literature on the interplay between gut microbiota, immune system, and metabolism.
  • Discussion of the role of innate immune receptors like Toll-like receptors (TLRs) in obesity.
  • Analysis of signaling pathways and cytokine production in response to microbial and dietary factors.

Main Results:

  • Obesity-induced immune impairment affects both innate and adaptive immunity.
  • Gut microbiota alterations and bacterial product translocation promote systemic inflammation.
  • TLR activation by microbial components and lipids triggers inflammatory pathways, leading to insulin resistance.
  • Gut microbiota-diet interactions influence T-cell differentiation and immune responses.

Conclusions:

  • Gut microbiota significantly influences whole-body metabolism by modulating immune system components.
  • Understanding these interactions is key to addressing obesity-associated co-morbidities.
  • Targeting the gut microbiota may offer therapeutic strategies for metabolic and inflammatory diseases.